Arecor Therapeutics (AREC) Stock Chart & Stock Price History GBX 39.40 +1.40 (+3.68%) As of 04/17/2025 12:29 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesBuy This Stock Arecor Therapeutics Stock Price Performance 5 Day Performance+3.68%1 Month Performance-18.34%3 Month Performance-30.88%6 Month Performance-46.76%Year-To-Date Performance-46.58%1 Year Performance-69.34% Receive AREC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Arecor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address AREC Stock Chart for Friday, April, 18, 2025 AREC Chart by TradingView Arecor Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/18/2025GBX 39.40GBX 39.40GBX 39.40GBX 38340,503 shs£14.88 million04/17/2025GBX 38.50GBX 39.40+2.34%GBX 39.40GBX 38340,503 shs£14.88 million04/16/2025GBX 36GBX 38.50+6.94%GBX 40GBX 36114,715 shs£14.54 million04/15/2025GBX 38GBX 36-5.26%GBX 36.10GBX 3656,446 shs£13.59 million04/14/2025GBX 38GBX 38GBX 38.67GBX 3814,309 shs£14.35 million04/11/2025GBX 38.50GBX 38.50GBX 40GBX 38.5015,637 shs£14.54 million04/10/2025GBX 36GBX 38.50+6.94%GBX 40GBX 38.5015,637 shs£14.54 million04/09/2025GBX 36.56GBX 36-1.53%GBX 40GBX 363,986 shs£13.59 million04/09/2025GBX 36.56GBX 36-1.53%GBX 40GBX 363,986 shs£13.59 million04/08/2025GBX 40GBX 36.56-8.60%GBX 38.89GBX 36.4012,126 shs£13.80 million Get the Latest News and Ratings for AREC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arecor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/08/2025GBX 40GBX 36.56-8.60%GBX 38.89GBX 36.4012,126 shs£13.80 million04/07/2025GBX 40GBX 40GBX 40.03GBX 39.207,159 shs£15.10 million04/04/2025GBX 40GBX 40GBX 40.03GBX 39.207,159 shs£15.10 million04/03/2025GBX 42GBX 40-4.76%GBX 43GBX 4073,300 shs£15.10 million04/02/2025GBX 42GBX 42GBX 42.10GBX 41.2020,599 shs£15.86 million04/01/2025GBX 42GBX 42GBX 43.50GBX 4270,955 shs£15.86 million03/31/2025GBX 42.33GBX 42-0.78%GBX 43.50GBX 42129,063 shs£15.86 million03/28/2025GBX 47.14GBX 42.33-10.21%GBX 48GBX 42.3329,002 shs£15.98 million03/27/2025GBX 47.95GBX 47.14-1.67%GBX 48GBX 47.1425,790 shs£17.80 million03/26/2025GBX 49GBX 47.95-2.15%GBX 51.50GBX 47.9516,492 shs£18.10 million03/25/2025GBX 48.25GBX 49+1.55%GBX 49.03GBX 48.254,281 shs£18.50 million03/24/2025GBX 49GBX 48.25-1.53%GBX 49.10GBX 48.252,882 shs£18.22 million03/21/2025GBX 49.33GBX 49.33GBX 49.33GBX 49123 shs£18.63 million03/20/2025GBX 48GBX 49.33+2.77%GBX 49.33GBX 49123 shs£18.63 million03/19/2025GBX 48.25GBX 48-0.52%GBX 49.50GBX 4811 shs£18.12 million03/18/2025GBX 48.25GBX 48.25GBX 49.50GBX 48.2522,057 shs£18.22 million03/17/2025GBX 48.02GBX 48.25+0.48%GBX 49.50GBX 48.2515,082 shs£18.22 million Related Companies SkinBioTherapeutics Stock Price Chart Tissue Regenix Group Stock Price Chart Futura Medical Stock Price Chart Sareum Stock Price Chart OptiBiotix Health Stock Price Chart Poolbeg Pharma Stock Price Chart ImmuPharma Stock Price Chart Synairgen Stock Price Chart Oxford BioDynamics Stock Price Chart IXICO Stock Price Chart Receive AREC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Arecor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (LON:AREC) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredTrump to unlock 15-figure fortune for America (May 3rd) ?Recently, President Trump decided to kill the coin, for good reason. It now costs 4 cents to make a single pen...Paradigm Press | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arecor Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Arecor Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.